english.elpais.com
3 days agoOMG science
A scientific rebellion to get Europe to approve a controversial Alzheimer's drug
Lecanemab represents a breakthrough for Alzheimer's treatment but faces significant controversy regarding its efficacy, safety, and accessibility. [ more ]